Congenital long QT 3 in the pediatric population

American Journal of Cardiology

Volumn 109, Issue 10, 2012, Pages 1459-1465

  Blaufox, Andrew D ^a   Tristani Firouzi, Martin ^b   Seslar, Stephen ^c   Sanatani, Shubhayan ^d   Trivedi, Bhavya ^e   Fischbach, Peter ^f   Paul, Thomas ^g   Young, Ming Lon ^h   Tisma Dupanovic, Svjetlana ⁱ   Silva, Jennifer ^j   Cuneo, Bettina ^k   Fournier, Anne ^l   Singh, Harinder ^m   Tanel, Ronn E ⁿ   Etheridge, Susan P ^b  

^a Northwell Health   (United States)

^b PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

^d BC CHILDREN S HOSPITAL   (Canada)

^e Pediatric Cardiology Associates/Pediatrix   (United States)

^f CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^g UNIVERSITY OF GÖTTINGEN   (Germany)

^h JOE DIMAGGIO CHILDREN S HOSPITAL   (United States)

ⁱ CHILDREN S MERCY HOSPITAL   (United States)

^j WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k ADVOCATE CHILDREN S HOSPITAL   (United States)

^l UNIVERSITY OF MONTREAL   (Canada)

^m CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; FLECAINIDE; METOPROLOL; MEXILETINE; NADOLOL; PROPRANOLOL; SODIUM CHANNEL NAV1.5;

ARTICLE; BEHAVIOR DISORDER; CHILD; CLINICAL ARTICLE; DEFIBRILLATOR; DRUG EFFECT; DRUG EFFICACY; FATIGUE; FEMALE; GENE MUTATION; HUMAN; LONG QT SYNDROME; LONG QT SYNDROME 3; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SINUS BRADYCARDIA; SYMPTOM; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; CHILD; CHILD, PRESCHOOL; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LONG QT SYNDROME; MALE; PREGNANCY; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84860430504     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.01.361     Document Type: Article

References (26)

1. P.J. Schwartz, S.G. Priori, C. Spazzolini, A.J. Moss, G.M. Vincent, C. Napolitano, I. Denjoy, P. Guicheney, G. Breithardt, M.T. Keating, J.A. Towbin, A.H. Beggs, P. Brink, A.A.M. Wilde, L. Toivonen, W. Zareba, J.L. Robinson, K.W. Timothy, V. Corfield, D. Wattaanasirichaigoon, C. Corbett, W. Haverkamp, E. Schulze-Bahr, M.H. Lehmann, K. Schwartz, P. Coumel, R. Bloise Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias Circulation 103 2001 89 95
2. S.G. Priori, C. Napolitano, P.J. Schwartz, M. Grillo, R. Bloise, E. Ronchetti, C. Monclavo, C. Tulipani, A. Veia, G. Bottelli, J. Nastoli Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers JAMA 292 2004 1341 1344
3. D.P. Zipes, A.J. Camm, M. Borggrefe, A.E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A.J. Moss, R.J. Myerburg, S.G. Priori, M.A. Quinones, D.M. Roden, M.J. Silka, C. Tracy ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e385 e484
4. S.P. Etheridge, S. Sanatani, M.I. Cohen, C.A. Albaro, E.V. Saarel, D.J. Bradley Long QT syndrome in children in the era of implantable defibrillators J Am Coll Cardiol 50 2007 1335 1340
5. P.J. Schwartz, C. Spazzolini, S.G. Priori, L. Crotti, A. Vincentini, M. Landolina, M. Gasparini, A.A.M. Wilde, R.E. Knops, I. Denjoy, L. Toivonen, G. Monning, M. Al-Fayyadh, L. Jordsens, M. Borggrefe, C. Holmgren, P. Brugada, L. De Roy, S.H. Hohnloser, P.A. Brink Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) registry Circulation 122 2010 1272 1282
6. P.J. Schwartz, C. Spazzolini, L. Crotti All LQT3 patients need an ICD: true or false? Heart Rhythm 6 2009 113 120
7. J.F. Liu, A.J. Moss, C. Jons, J. Benhorin, P.J. Schwartz, C. Spazzolini, L. Crotti, M.J. Ackerman, S. McNitt, J.L. Robinson, M. QI, I. Goldenberg, W. Zareba Mutation-specific risk in two genetic forms of type 3 long QT syndrome Am J Cardiol 105 2010 210 213
8. P.L. Hedley, P. Jergensen, R. Schlamowitz, R. Wangari, J. Moolman-Smook, P.A. Brink, J.K. Kanters, V.A. Corfield, M. Christiansen The genetic basis of long QT and short QT syndromes: a mutation update Hum Mutat 30 2009 1486 1511
9. M.E. Anderson, S.M. Al-Khatib, D.M. Roden, R.M. Califf Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management Am Heart J 144 2002 769 781
10. N.G. Kambouris, H.B. Nuss, D.C. Johns, E. Marban, G.F. Tomaselli, J.R. Balser A revised view of cardiac sodium channel "blockade" in the long-QT syndrome J Clin Invest 105 2000 1133 1140
11. C. Donger, I. Denjoy, M. Berthet, N. Neyroud, C. Cruaud, M. Bennaceur, G. Chivoret, K. Schwartz, P. Coumel, P. Guicheney KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome Circulation 96 1997 2778 2781
12. W. Zareba, A.J. Moss, P.J. Schwartz, G.M. Vincent, J.L. Robinson, S.G. Priori, J. Benhorin, E.H. Locati, J.A. Towbin, M.T. Keating, M.H. Lehmann, W.J. Hall International Long-QT Syndrome Registry Research Group Influence of genotype on the clinical course of the long-QT syndrome N Engl J Med 339 1998 960 965
13. W. Zareba, A.J. Moss, E.H. Locati, M.H. Lehmann, D.R. Peterson, W.J. Hall, P.J. Schwartz, G.M. Vincent, S.G. Priori, J. Benhorin, J.A. Towbin, J.L. Robinson, M.L. Andrews, C. Napolitano, K. Timothy, L. Zhang, A. Medina International Long QT Registry Modulating effects of age and gender on the clinical course of long QT syndrome by genotype J Am Coll Cardiol 42 2003 103 109
14. I. Goldenberg, A.J. Moss, D.R. Peterson, S. McNitt, W. Zareba, M.L. Andrews, J.L. Robinson, E.H. Locatti, M.J. Ackerman, J. Benhorin, E.S. Kaufman, C. Napolitano, S.G. Priori, M. Qi, P.J. Schwartz, J.A. Towbin, G.M. Vincent, L. Zhang Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome Circulation 117 2008 2184 2191
15. J.B. Hobbs, D.R. Peterson, A.J. Moss, S. McNitt, W. Zareba, I. Goldenberg, M. Qi, J.L. Robinson, A.J. Sauer, M.J. Ackerman, J. Benhorin, E.S. Kaufman, E.H. Locati, C. Napolitano, S.G. Priori, J.A. Towbin, G.M. VIncent, L. Zhang Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome JAMA 296 2006 1249 1254
16. C.I. Berul, G.F. Van Hare, N.J. Kertesz, A.M. Dubin, F. Cecchin, K.K. Collins, B.C. Cannon, M.E. Alexander, J.K. Triedman, E.P. Walsh, R.A. Friedman Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients J Am Coll Cardiol 51 2008 1685 1691
17. J.M. Horner, M. Kinoshita, T.L. Webster, C.M. Haglund, P.A. Friedman, M.J. Ackerman Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience Heart Rhythm 7 2010 1616 1622
18. Y. Ruan, N. Liu, R. Bloise, C. Napolitano, S.G. Priori Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients Circulation 116 2007 1137 1144
19. E. Schulze-Bahr, H. Fenge, D. Etzrodt, W. Haverkamp, G. Monnig, H. Wedekind, G. Breithardt, H.G. Kehl Long QT syndrome and life threatening arrhythmia in a newborn: molecular diagnosis and treatment response Heart 90 2004 13 16
20. P.J. Schwartz, S.G. Priori, E.H. Locati, C. Napolitano, F. Cantu, J.A. Towbin, M.T. Keating, H. Hammoude, A.M. Brown, L.S.K. Chen, T.J. Colatsky Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate Implications for gene-specific therapy Circulation 92 1995 3381 3386
21. J. Benhorin, R. Taub, M. Goldmit, B. Kerem, R.S. Kass, I. Windman, A. Medina Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome? Circulation 101 2000 1698 1706
22. A.J. Moss, J.R. Windle, W.J. Hall, W. Zareba, J.L. Robinson, S. McNitt, P. Severski, S. Rosero, J.P. Daubert, M. Qi, M. Cieciorka, A.S. Manalan Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial Ann Noninvasive Electrocardiol 10 2005 59 66
23. L. Fabritz, D. Damke, M. Emmerich, S.G. Kaufmann, K. Theis, A. Blana, L. Fortmuller, S. Laakmann, S. Hermann, E. Aleynichenko, J. Steinfurt, D. Volkery, B. Riemann, U. Kirchhefer, M.R. Franz, G. Breithardt, E. Carmeliet, M. Schafers, S.K. Maier, P. Carmeliet, P. Kirchhof Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3 Cardiovasc Res 87 2010 60 72
24. C.R. Bezzina, M.B. Rook, W.A. Groenewegen, H. Le Marer, T.M. Hoorntje, S. Demolombe, I. Baro, D. Escande, H.J. Jongsma, A.A. Wilde, M.B. Rook Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system Circ Res 92 2003 159 168
25. D.J. Tester, C. Valdivia, C. Harris-Kerr, M. Alders, B.A. Salisbury, A.A. Wilde, J.C. Makielski, M.J. Ackerman Epidemiologic, molecular, and functional evidence suggest A572D-SCN5A should not be considered an independent LQT3-susceptibility mutation Heart Rhythm 7 2010 912 919
26. D.J. Tester, M.L. Will, C.M. Haglund, M.J. Ackerman Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing Heart Rhythm 2 2005 507 517